Literature DB >> 27461064

HLA polymorphism and risk of multiple myeloma.

Meral Beksac1, Loren Gragert2, Stephanie Fingerson2, Martin Maiers2, Mei-Jie Zhang3,4, Mark Albrecht2, Xiaobo Zhong3, Wendy Cozen5, Angela Dispenzieri6, Sagar Lonial7, Parameswaran Hari3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27461064      PMCID： PMC5134914          DOI： 10.1038/leu.2016.199

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  18 in total

1.  Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States.

Authors:  Ola Landgren; Gloria Gridley; Ingemar Turesson; Neil E Caporaso; Lynn R Goldin; Dalsu Baris; Thomas R Fears; Robert N Hoover; Martha S Linet
Journal:  Blood       Date:  2005-10-06       Impact factor: 22.113

2.  Six-locus high resolution HLA haplotype frequencies derived from mixed-resolution DNA typing for the entire US donor registry.

Authors:  Loren Gragert; Abeer Madbouly; John Freeman; Martin Maiers
Journal:  Hum Immunol       Date:  2013-06-24       Impact factor: 2.850

3.  Sumoylated HSP90 is a dominantly inherited plasma cell dyscrasias risk factor.

Authors:  Klaus-Dieter Preuss; Michael Pfreundschuh; Martin Weigert; Natalie Fadle; Evi Regitz; Boris Kubuschok
Journal:  J Clin Invest       Date:  2015-05-01       Impact factor: 14.808

4.  Human leukocyte antigen class I and II alleles in non-Hodgkin lymphoma etiology.

Authors:  Sophia S Wang; Amr M Abdou; Lindsay M Morton; Rasmi Thomas; James R Cerhan; Xiaojiang Gao; Wendy Cozen; Nathaniel Rothman; Scott Davis; Richard K Severson; Leslie Bernstein; Patricia Hartge; Mary Carrington
Journal:  Blood       Date:  2010-04-12       Impact factor: 22.113

5.  Clonal Immunoglobulin against Lysolipids in the Origin of Myeloma.

Authors:  Shiny Nair; Andrew R Branagan; Jun Liu; Chandra Sekhar Boddupalli; Pramod K Mistry; Madhav V Dhodapkar
Journal:  N Engl J Med       Date:  2016-02-11       Impact factor: 91.245

6.  Hyperphosphorylation of autoantigenic targets of paraproteins is due to inactivation of PP2A.

Authors:  Klaus-Dieter Preuss; Michael Pfreundschuh; Natalie Fadle; Evi Regitz; Sybille Raudies; Niels Murwaski; Manfred Ahlgrimm; Joerg Bittenbring; Markus Klotz; Karl-Herbert Schäfer; Gerhard Held; Frank Neumann; Sandra Grass
Journal:  Blood       Date:  2011-07-26       Impact factor: 22.113

7.  Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance.

Authors:  Celine M Vachon; Robert A Kyle; Terry M Therneau; Barbara J Foreman; Dirk R Larson; Colin L Colby; Tara K Phelps; Angela Dispenzieri; Shaji K Kumar; Jerry A Katzmann; S Vincent Rajkumar
Journal:  Blood       Date:  2009-01-29       Impact factor: 22.113

8.  Genetic polymorphism of NK receptors and their ligands in melanoma patients: prevalence of inhibitory over activating signals.

Authors:  Elissaveta Naumova; Anastassia Mihaylova; Konstantin Stoitchkov; Milena Ivanova; Ludmila Quin; Miglena Toneva
Journal:  Cancer Immunol Immunother       Date:  2004-07-10       Impact factor: 6.968

9.  HLA specificities are related to development and prognosis of diffuse large B-cell lymphoma.

Authors:  Miguel Alcoceba; Elena Sebastián; Luis Marín; Ana Balanzategui; M Eugenia Sarasquete; M Carmen Chillón; Cristina Jiménez; Noemí Puig; Rocío Corral; Emilia Pardal; Carlos Grande; José Luis Bello; Carmen Albo; Fátima de la Cruz; Carlos Panizo; Alejandro Martín; Eva González-Barca; M Dolores Caballero; Jesús F San Miguel; Ramón García-Sanz; Marcos González
Journal:  Blood       Date:  2013-07-10       Impact factor: 22.113

10.  Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk.

Authors:  Daniel Chubb; Niels Weinhold; Peter Broderick; Bowang Chen; David C Johnson; Asta Försti; Jayaram Vijayakrishnan; Gabriele Migliorini; Sara E Dobbins; Amy Holroyd; Dirk Hose; Brian A Walker; Faith E Davies; Walter A Gregory; Graham H Jackson; Julie A Irving; Guy Pratt; Chris Fegan; James Al Fenton; Kai Neben; Per Hoffmann; Markus M Nöthen; Thomas W Mühleisen; Lewin Eisele; Fiona M Ross; Christian Straka; Hermann Einsele; Christian Langer; Elisabeth Dörner; James M Allan; Anna Jauch; Gareth J Morgan; Kari Hemminki; Richard S Houlston; Hartmut Goldschmidt
Journal:  Nat Genet       Date:  2013-08-18       Impact factor: 38.330
View more
  8 in total

Review 1.  Racial disparities, cancer and response to oxidative stress.

Authors:  Jie Zhang; Zhi-Wei Ye; Danyelle M Townsend; Chanita Hughes-Halbert; Kenneth D Tew
Journal:  Adv Cancer Res       Date:  2019-04-23       Impact factor: 6.242

2.  The Human Immunopeptidome Project: A Roadmap to Predict and Treat Immune Diseases.

Authors:  Juan Antonio Vizcaíno; Peter Kubiniok; Kevin A Kovalchik; Qing Ma; Jérôme D Duquette; Ian Mongrain; Eric W Deutsch; Bjoern Peters; Alessandro Sette; Isabelle Sirois; Etienne Caron
Journal:  Mol Cell Proteomics       Date:  2019-11-19       Impact factor: 5.911

Review 3.  Biological determinants of health disparities in multiple myeloma.

Authors:  Cheryl Jacobs Smith; Stefan Ambs; Ola Landgren
Journal:  Blood Cancer J       Date:  2018-08-28       Impact factor: 11.037

4.  The association of HLA-C alleles with multiple myeloma in Chinese patients.

Authors:  Xiaojing Wang; Gang An; Jiying Wang; Yan Zhang; Qinghua Li; Hui Wei; Lugui Qiu; Kun Ru
Journal:  Exp Hematol Oncol       Date:  2018-08-23

Review 5.  Germline Risk Contribution to Genomic Instability in Multiple Myeloma.

Authors:  Siegfried Janz; Fenghuang Zhan; Fumou Sun; Yan Cheng; Michael Pisano; Ye Yang; Hartmut Goldschmidt; Parameswaran Hari
Journal:  Front Genet       Date:  2019-05-08       Impact factor: 4.599

6.  Transcriptome-wide association study of multiple myeloma identifies candidate susceptibility genes.

Authors:  Molly Went; Ben Kinnersley; Amit Sud; David C Johnson; Niels Weinhold; Asta Försti; Mark van Duin; Giulia Orlando; Jonathan S Mitchell; Rowan Kuiper; Brian A Walker; Walter M Gregory; Per Hoffmann; Graham H Jackson; Markus M Nöthen; Miguel Inacio da Silva Filho; Hauke Thomsen; Annemiek Broyl; Faith E Davies; Unnur Thorsteinsdottir; Markus Hansson; Martin Kaiser; Pieter Sonneveld; Hartmut Goldschmidt; Kari Stefansson; Kari Hemminki; Björn Nilsson; Gareth J Morgan; Richard S Houlston
Journal:  Hum Genomics       Date:  2019-08-20       Impact factor: 4.639

7.  dCATCH-Seq: improved sequencing of large continuous genomic targets with double-hybridization.

Authors:  Yanfeng Zhang; Jun Song; Kenneth Day; Devin Absher
Journal:  BMC Genomics       Date:  2017-10-23       Impact factor: 3.969

Review 8.  Prevention Is the Best Treatment: The Case for Understanding the Transition from Monoclonal Gammopathy of Undetermined Significance to Myeloma.

Authors:  Michael H Tomasson; Mahmoud Ali; Vanessa De Oliveira; Qian Xiao; Yogesh Jethava; Fenghuang Zhan; Adam M Fitzsimmons; Melissa L Bates
Journal:  Int J Mol Sci       Date:  2018-11-16       Impact factor: 5.923
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.